Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0867
Source ID: NCT02328222
Associated Drug: Esw Group
Title: ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION
Acronym: ESWMEX001
Status: COMPLETED
Study Results: NO
Results:
Conditions: END STAGE RENAL DISEASE
Interventions: DRUG: ESW group
Outcome Measures: Primary: ACUTE REJECTION FREQUENCY AND SEVERITY, ACUTE REJECTION ACCORDING TO BANFF´S CLASSIFICATION, LIMITROPHIC CHANGES (1), ACUTE REJECTION 1A (2), 1B (3), 2A (4), 2B (5); CHRONIC REJECTION (6), UP TO 1 YEAR OF FOLLOW UP | Secondary: RENAL GRAFT FUNCTION, GRAFT FUNCTION IS MEASURED BY eGFR USING MDRD-4 FORMULAE, RESULTS ARE SHOWN IN ML/MIN, UP TO 1 YEAR OF FOLLOW UP
Sponsor/Collaborators: Sponsor: Unidad de Investigacion Medica en Enfermedades Renales
Gender: ALL
Age: ADULT
Phases: PHASE4
Enrollment: 71
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2010-06
Completion Date: 2011-06
Results First Posted:
Last Update Posted: 2014-12-31
Locations: Umae Hospital de Especialidades, Guadalajara, Jalisco, 44290, Mexico
URL: https://clinicaltrials.gov/show/NCT02328222